Detalles de la búsqueda
1.
Long-acting capsid inhibitor protects macaques from repeat SHIV challenges.
Nature;
601(7894): 612-616, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875675
2.
Antiviral Activity of Lenacapavir Against HIV-2 Isolates and Drug-resistant HIV-2 Mutants.
J Infect Dis;
2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38060982
3.
Antiviral activity of tenofovir alafenamide (TAF) against HIV-1 clinical isolates harboring K65R.
J Med Virol;
95(4): e28723, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37185867
4.
Rapid HIV-1 genotyping assay for the detection of capsid mutations.
J Med Virol;
95(12): e29292, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38063404
5.
Resistance Analyses in Highly Treatment-Experienced People With Human Immunodeficiency Virus (HIV) Treated With the Novel Capsid HIV Inhibitor Lenacapavir.
J Infect Dis;
226(11): 1985-1991, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082606
6.
Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study.
J Antimicrob Chemother;
77(4): 989-995, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028668
7.
Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes.
Antimicrob Agents Chemother;
65(3)2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33288639
8.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Lancet;
396(10246): 239-254, 2020 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711800
9.
Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection.
J Antimicrob Chemother;
76(3): 692-698, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33202006
10.
Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V.
Antimicrob Agents Chemother;
64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31988104
11.
Differential detection of M184V/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCs.
J Antimicrob Chemother;
75(8): 2249-2252, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32413134
12.
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
J Antimicrob Chemother;
75(6): 1588-1590, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154864
13.
Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.
J Infect Dis;
220(11): 1826-1833, 2019 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362305
14.
Development of an HIV-1 integrase genotyping assay for HIV-1 subtype AE.
J Med Virol;
91(5): 890-893, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548936
15.
Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-naïve individuals.
J Med Virol;
91(12): 2188-2194, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31389026
16.
Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.
J Infect Dis;
215(6): 920-927, 2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28453836
17.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Lancet;
385(9987): 2606-15, 2015 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25890673
18.
Rare emergence of drug resistance in HIV-1 treatment-naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.
HIV Clin Trials;
17(2): 78-87, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26892863
19.
Characterization of HIV-1 Resistance to Tenofovir Alafenamide In Vitro.
Antimicrob Agents Chemother;
59(10): 5917-24, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26149983
20.
In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate.
Antimicrob Agents Chemother;
59(10): 5909-16, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26149992